Literature DB >> 3064030

Demonstration of soluble Plasmodium falciparum antigens reactive with Limulus amoebocyte lysate and polymyxin B.

P H Jakobsen1, L Baek, S Jepsen.   

Abstract

To investigate whether soluble Plasmodium falciparum antigens possess endotoxin-like properties, the interaction of Limulus amoebocyte lysate (LAL) with defined soluble antigens from Plasmodium falciparum was studied by various crossed immunoelectrophoretic methods and immunoblotting. The soluble P. falciparum antigens were purified by affinity chromatography using human IgG from malaria-immune adults as ligand. Of eight possible antigens, at least three were affected by LAL, as indicated by disappearance of these antigens in the precipitation pattern, after the reaction with LAL. One of the LAL-reactive antigens is a heat-stable glycoprotein with the presence of both hydrophilic and hydrophobic regions in its structure. This antigen shows a strong reaction with polymyxin B, and antibodies against it have been shown to be inhibitory to the growth of P. falciparum in culture. It is concluded that LAL reacts with several soluble antigens from P. falciparum and it is suggested that these antigens participate in the induction of protective immunity to malaria, and consequently that one or more of the soluble antigens are candidates for a malaria vaccine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064030     DOI: 10.1111/j.1365-3024.1988.tb00247.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  8 in total

1.  Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages.

Authors:  J Taverne; C A Bate; D Kwiatkowski; P H Jakobsen; J H Playfair
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages.

Authors:  C Moreno; J Taverne; A Mehlert; C A Bate; R J Brealey; A Meager; G A Rook; J H Playfair
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

3.  Decreased antitoxic activities among children with clinical episodes of malaria.

Authors:  P H Jakobsen; V McKay; R N'Jie; B O Olaleye; U D'Alessandro; G H Zhang; T A Eggelte; C Koch; B M Greenwood
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  Induction of circulating group II phospholipase A2 expression in adults with malaria.

Authors:  P Vadas; J Keystone; E Stefanski; K Scott; W Pruzanski
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

5.  Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.

Authors:  C A Bate; J Taverne; A Davé; J H Playfair
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

6.  Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors.

Authors:  Pedro Mejia; Monica Diez-Silva; Faustin Kamena; Fengxin Lu; Stacey M Fernandes; Peter H Seeberger; Alvin E Davis; James R Mitchell
Journal:  J Infect Dis       Date:  2015-09-07       Impact factor: 5.226

Review 7.  Endotoxemia: methods of detection and clinical correlates.

Authors:  J C Hurley
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

8.  Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo.

Authors:  C A Bate; J Taverne; J H Playfair
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.